The pharmacokinetic profile on the therapeutic dose range in human beings needs to be determined, as scientific studies with rodents point out that increased doses end in non-linear PK profile, and subjective outcomes at higher doses may possibly rely on the CYP2D6 genotype.The preliminary therapeutic proof, along with the prospective pharmacologic